Literature DB >> 16628013

Cell cycling through Cdc25A: transducer of cytokine proliferative signals.

C Kittipatarin1, W Q Li, D V Bulavin, S K Durum, A R Khaled.   

Abstract

A balance between survival and proliferative signals maintains a constant number of T lymphocytes that populate the mammalian immune system, a process termed "homeostasis". Central to this process is the availability of a stromal cell product--the cytokine interleukin-7 (IL-7). We recently showed that IL-7, in addition to protecting cells from apoptosis, drives the cell cycling of lymphocytes through regulation of the stability of the phosphatase, Cdc25A, a key activator of cyclin-dependent kinases (cdks). IL-7 achieves this by controlling the activity of p38 MAP kinase (MAPK), which can phosphorylate Cdc25A, triggering its degradation. Sustained expression of Cdc25A had diverse effects: it promoted cell cycling, even in presence of cell cycle inhibitors such p27Kip1, and prevented cell shrinkage in response to cytokine deprivation. Herein we show a role for Cdc25A as a transducer of cytokine-driven proliferation and discuss novel implications for cell growth from the perspective of the requirements for maintenance of lymphocyte homeostasis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16628013     DOI: 10.4161/cc.5.9.2693

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  9 in total

1.  CyclinD-CDK4/6 complexes phosphorylate CDC25A and regulate its stability.

Authors:  C Dozier; L Mazzolini; C Cénac; C Froment; O Burlet-Schiltz; A Besson; S Manenti
Journal:  Oncogene       Date:  2017-02-13       Impact factor: 9.867

2.  The interaction of LCK and the CD4 co-receptor alters the dose response of T-cells to interleukin-7.

Authors:  Christina Kittipatarin; Nuska Tschammer; Annette R Khaled
Journal:  Immunol Lett       Date:  2010-04-28       Impact factor: 3.685

3.  Cdc25A-driven proliferation regulates CD62L levels and lymphocyte movement in response to interleukin-7.

Authors:  Christina Kittipatarin; Wenqing Li; Scott K Durum; Annette R Khaled
Journal:  Exp Hematol       Date:  2010-09-08       Impact factor: 3.084

4.  Downregulation of P38 phosphorylation correlates with low-grade differentiation and proliferation of lung squamous cell carcinoma.

Authors:  Yandong Nan; Ruijing Chang; Hua Jiang; Shuanying Yang; Faguang Jin; Yonghong Xie
Journal:  Am J Transl Res       Date:  2017-04-15       Impact factor: 4.060

5.  PD-1 inhibits T cell proliferation by upregulating p27 and p15 and suppressing Cdc25A.

Authors:  Nikolaos Patsoukis; Duygu Sari; Vassiliki A Boussiotis
Journal:  Cell Cycle       Date:  2012-10-03       Impact factor: 4.534

Review 6.  Interlinking interleukin-7.

Authors:  Christina Kittipatarin; Annette R Khaled
Journal:  Cytokine       Date:  2007-09-04       Impact factor: 3.861

7.  Ex vivo expansion of memory CD8 T cells from lymph nodes or spleen through in vitro culture with interleukin-7.

Authors:  Christina Kittipatarin; Annette R Khaled
Journal:  J Immunol Methods       Date:  2009-03-17       Impact factor: 2.303

8.  Imatinib mesylate inhibits STAT5 phosphorylation in response to IL-7 and promotes T cell lymphopenia in chronic myelogenous leukemia patients.

Authors:  S Thiant; M M Moutuou; P Laflamme; R Sidi Boumedine; D M Leboeuf; L Busque; J Roy; M Guimond
Journal:  Blood Cancer J       Date:  2017-04-07       Impact factor: 11.037

9.  UnCHKed DNA replication: A stressful matter.

Authors:  Jennifer L Gryp; Gustavo J Gutierrez
Journal:  Cell Cycle       Date:  2012-10-03       Impact factor: 4.534

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.